About Volcano (NASDAQ:VOLC)
Volcano Corporation designs, develops, manufactures and commercializes a suite of precision guided therapy tools including intravascular ultrasound (IVUS) and fractional flow reserve (FFR) products. The Company markets its products to physicians, nurses and technicians who perform endovascular based coronary and peripheral interventional procedures in hospitals and to other personnel who make purchasing decisions on behalf of hospitals. The Company’s products consist of consoles that are marketed as stand-alone units or as units that can be integrated into a variety of hospital-based interventional surgical suites called catheterization laboratories, or cath labs. The Company has developed customized cath lab versions of these consoles. The Company sells products directly to customers in the United States, Japan, certain European markets and South Africa. The Company’s products include consoles, IVUS products, FFR products, Pioneer plus re-entry catheter and crux VCF system.
Industry, Sector and Symbol
Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Equipment
SectorAdvanced Medical Equipment & Technology - NEC
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-10.48%
Return on Assets-3.68%
Volcano (NASDAQ:VOLC) Frequently Asked Questions
What is Volcano's stock symbol?
Volcano trades on the NASDAQ under the ticker symbol "VOLC."
How were Volcano's earnings last quarter?
Volcano Corp (NASDAQ:VOLC) issued its quarterly earnings data on Thursday, November, 6th. The healthcare company reported ($0.04) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.06) by $0.02. The healthcare company had revenue of $97.50 million for the quarter, compared to analysts' expectations of $96 million. Volcano had a negative return on equity of 10.48% and a negative net margin of 8.21%. The company's revenue for the quarter was up 1.8% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.08) EPS. View Volcano's Earnings History.
Who are some of Volcano's key competitors?
Some companies that are related to Volcano include Accelerate Diagnostics (AXDX), Quidel (QDEL), Mazor Robotics (MZOR), Natus Medical (BABY), Abaxis (ABAX), Luminex (LMNX), LeMaitre Vascular (LMAT), Viewray (VRAY), Accuray (ARAY), Pacific Biosciences of California (PACB), GenMark Diagnostics (GNMK), Corindus Vascular Robotics (CVRS), Cytosorbents (CTSO), Cogentix Medical (CGNT), Alliance HealthCare Services (AIQ), Harvard Bioscience (HBIO), Viveve Medical (VIVE) and IRIDEX (IRIX).
How do I buy Volcano stock?
Shares of Volcano can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How big of a company is Volcano?
Volcano has a market capitalization of $928.46 million.
How can I contact Volcano?
Volcano's mailing address is 3721 Valley Centre Dr Ste 500, SAN DIEGO, CA 92130-3328, United States. The healthcare company can be reached via phone at +1-800-2284728.
MarketBeat Community Rating for Volcano (VOLC)MarketBeat's community ratings are surveys of what our community members think about Volcano and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Volcano (NASDAQ:VOLC) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Volcano (NASDAQ:VOLC) Earnings History and Estimates Chart
Volcano (NASDAQ VOLC) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/6/2014||Q314||($0.06)||($0.04)||$96.00 million||$97.50 million||View||N/A|
|8/7/2014||Q214||($0.05)||$0.01||$103.14 million||$102.60 million||View||Listen|
|5/2/2014||Q1||($0.11)||($0.12)||$94.69 million||$94.50 million||View||Listen|
|2/24/2014||Q413||($0.24)||($0.29)||$103.03 million||$103.30 million||View||Listen|
|11/4/2013||Q313||($0.01)||($0.08)||$97.20 million||$95.80 million||View||N/A|
|8/5/2013||Q2 2013||($0.01)||$0.03||$97.90 million||$101.30 million||View||N/A|
|5/2/2013||Q1 2013||$0.02||$96.11 million||$93.20 million||View||N/A|
|2/21/2013||Q4 2012||$0.09||$0.04||$102.48 million||$102.48 million||View||N/A|
|11/6/2012||Q312||$0.04||$0.04||$95.37 million||$93.65 million||View||N/A|
Volcano (NASDAQ:VOLC) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Volcano (NASDAQ:VOLC)
No dividend announcements for this company have been tracked by MarketBeat.com
Volcano (NASDAQ VOLC) Insider Trading and Institutional Ownership History
Volcano (NASDAQ VOLC) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|1/2/2015||Joe Burnett||EVP||Sell||1,146||$17.88||$20,490.48|| |
|1/2/2015||John T Dahldorf||CFO||Sell||2,051||$17.88||$36,671.88|| |
|12/17/2014||R Scott Huennekens||Insider||Sell||30,000||$17.83||$534,900.00|| |
|6/12/2014||Heather S Ace||EVP||Sell||2,211||$18.24||$40,328.64|| |
|4/15/2014||David Sheehan||EVP||Sell||1,892||$19.36||$36,629.12|| |
|4/15/2014||John Dahldorf||CFO||Sell||2,176||$19.36||$42,127.36|| |
|3/19/2014||Darin Lippoldt||EVP||Sell||1,377||$23.03||$31,712.31|| |
|2/28/2014||David Sheehan||EVP||Sell||1,446||$21.72||$31,407.12|| |
|2/28/2014||John Dahldorf||CFO||Sell||1,244||$21.72||$27,019.68|| |
|2/20/2014||David Sheehan||EVP||Sell||1,595||$21.86||$34,866.70|| |
|2/20/2014||John Dahldorf||CFO||Sell||2,054||$21.86||$44,900.44|| |
|2/19/2014||Jorge Quinoy||Insider||Sell||6,357||$21.96||$139,599.72|| |
|2/6/2014||David Sheehan||EVP||Sell||1,584||$20.61||$32,646.24|| |
|2/6/2014||John Dahldorf||CFO||Sell||1,393||$20.61||$28,709.73|| |
|2/6/2014||R Scott Huennekens||Insider||Sell||4,730||$20.61||$97,485.30|| |
|1/17/2014||R Scott Huennekens||Insider||Sell||160,000||$21.12||$3,379,200.00|| |
|1/6/2014||John Dahldorf||CFO||Sell||47,423||$21.94||$1,040,460.62|| |
|1/2/2014||R Scott Huennekens||Insider||Sell||3,506||$21.68||$76,010.08|| |
|9/17/2013||Jorge Quinoy||Insider||Sell||5,000||$24.00||$120,000.00|| |
|5/24/2013||Alexis V Lukianov||Director||Buy||3,000||$16.93||$50,790.00|| |
|3/4/2013||Ronald A Matricaria||Director||Buy||20,000||$21.50||$430,000.00|| |
|12/3/2012||Jorge J Quinoy||Insider||Sell||6,750||$26.65||$179,887.50|| |
Volcano (NASDAQ VOLC) News Headlines
Volcano (NASDAQ:VOLC) SEC Filings
Volcano (NASDAQ:VOLC) Income Statement, Balance Sheet and Cash Flow Statement
Volcano (NASDAQ VOLC) Stock Chart for Monday, December, 11, 2017